Novo Nordisk | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
ANI Pharmaceuticals USD 436.76M 18.14M 2025-06
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD 147M 1.33B 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 18.27B 2.43B 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Novo Nordisk 168.07B 29.53B 2025-06
Novo Nordisk DKK 138.54B 18.02B 2025-03
Pacira USD 757.77M 40.77M 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Prestige Brands USD 1.86B 20.58M 2025-06
Sanofi 70.28B 3.8B 2025-06
Supernus Pharmaceuticals USD 1.06B 33.2M 2025-06
Zoetis USD 4.98B 322M 2025-06


Novo Nordisk Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.